인공 추간판 치환 시장 규모, 점유율, 동향 분석 리포트 : 재료 유형별, 적응증별, 최종 용도별, 지역별, 부문 예측(2024-2030년)

Artificial Disc Replacement Market Size, Share & Trends Analysis Report By Material Type (Metal + Plastic), By Indication (Cervical, Lumbar), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

인공 추간판 치환 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 인공 추간판 치환 시장 규모는 2030년까지 13억 4,000만 달러에 달하며, 2024-2030년 12.2%의 CAGR로 성장할 것으로 예측됩니다.

시장은 2021-2028년까지 11.7%의 유리한 CAGR로 성장할 것으로 예상됩니다. 시장 성장을 가속하는 주요 요인으로는 전 세계 척추 수술 건수 증가, 고령화 인구 증가, 조직 파괴가 적은 대체 수술에 대한 높은 수요, 기술 발전 등이 있으며, COVID-19 팬데믹으로 인해 물류 병목 현상, 수요 감소, 판매 및 마케팅 활동 감소와 같은 여러 가지 과제가 발생하였습니다.

이는 공급망 문제, 선택적 수술 연기 및 취소, 봉쇄로 인한 이동 제한에 기인합니다. 예를 들어 Zimmer Biomet은 COVID-19가 2020년 연간 매출에 부정적인 영향을 미쳤으며, 2019-2020년까지 총 매출이 12% 감소할 것이라고 보고했습니다. 이 회사는 또한 Medtronic의 제품을 사용하는 선택적 및 준 선택적 수술이 연기되어 COVID-19 이외의 응급 수술을 받기를 꺼려하는 사람들이 기업 매출에 영향을 미쳤다고 밝혔습니다.

조직 손상과 환자의 외상이 적고 외과적 치료가 널리 받아들여지면 시장 성장을 가속할 것으로 예상됩니다. 또한 시장 세분화에서 척추 분야공급업체 통합이 증가할 것으로 예상되며, 이는 시장 기회를 제공할 것으로 예상됩니다. 이는 기술 발전 증가로 인해 더욱 보완될 것으로 예상됩니다.

시장의 성장은 시장 기업의 인공 추간판 관련 임상시험 증가에 의해서도 지원되고 있습니다. 예를 들어 메드트로닉(Medtronic)은 경추 퇴행성 추간판 탈출증, 신경근병증, 척수증 치료를 위한 프레스티지 LP 경추 추간판 관련 임상시험을 후원하고 있습니다. 이 연구는 2022년 8월까지 완료될 예정입니다. 이러한 활동은 시장에 다양한 성장 기회를 제공합니다.

시장 진출기업은 시장 경쟁력을 유지하기 위해 인수, 합병, 제휴, 제품 출시 등 다양한 전략적 구상에 투자하고 있습니다. 예를 들어 2021년 2월 NuVasive, Inc.는 경추 추간판 전치환술용 인공 추간판 'Simplify Cervical Artificial Disc'를 개발한 Simplify Medical을 인수했습니다.

인공 추간판 치환 시장 보고서 하이라이트

• 2023년 시장 규모는 6억 3,900만 달러로 예측 기간 중 12.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
• 만성 요통으로 인한 추간판 퇴행성 질환의 유병률 증가로 인해 전 세계에서 척추 수술 건수가 증가하고 있습니다. 이는 시장 성장을 가속하는 주요 요인 중 하나입니다.
• 2023년에는 인공 추간판 제조에 플라스틱이 널리 사용됨에 따라 금속 + 플라스틱 소재 유형 부문이 시장을 주도했지만, 금속 부문은 이 부문의 연구 활동 증가로 인해 큰 점유율을 차지할 것으로 예상됩니다.
• 경추 추간판 치환술 부문은 높은 제품 가용성으로 인해 2023년 시장에서 가장 큰 점유율을 차지했습니다.
• 북미는 이 지역의 주요 기업의 존재로 인해 2023년 세계 시장에서 49.97% 이상의 매출 점유율을 차지하며 선두를 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 인공 추간판 치환 시장 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 인공 추간판 치환 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석
  • 파이프라인 분석

제4장 인공 추간판 치환 시장 : 재료 유형별 추정·동향 분석

• 세계의 인공 추간판 치환 시장 : 재료 유형별 대시보드
• 세계의 인공 추간판 치환 시장 : 재료 유형별 변동 분석
• 세계의 인공 추간판 치환 시장 : 재료 유형별 매출
• 금속
• 금속+플라스틱

제5장 인공 추간판 치환 시장 : 적응증별 추정·동향 분석

• 세계의 인공 추간판 치환 시장 : 적응증별 대시보드
• 세계의 인공 추간판 치환 시장 : 적응증별 변동 분석
• 세계의 인공 추간판 치환 시장 : 적응증별 매출
• 경추 추간판 치환술
• 요추 추간판 치환술

제6장 인공 추간판 치환 시장 : 최종 용도별 추정·동향 분석

• 세계의 인공 추간판 치환 시장 : 최종 용도별 대시보드
• 세계의 인공 추간판 치환 시장 : 최종 용도별 변동 분석
• 세계의 인공 추간판 치환 시장 : 최종 용도별 매출
• 병원
• 외래 시설

제7장 인공 추간판 치환 시장 : 재료 유형, 적응증, 최종 용도별 지역별 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년 :
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 기업/경쟁 분류
• 벤더 구도
  • 주요 판매 대리점 및 채널 파트너 리스트
  • 주요 고객
  • 주요 기업의 시장 점유율 분석, 2023년
  • Medtronic
  • Orthofix Medical Inc.
  • Globus Medical
  • Aesculap, Inc.
  • NuVasive, Inc.
  • AxioMed LLC
  • Zimmer Biomet
  • SpineArt SA
  • Synergy Spine Solutions Inc.
  • Centinel Spine
  • Johnson &Johnson
  • B Braun Melsungen
  • Evospine
  • Stryker Corporation

KSA

영문 목차

영문목차

Artificial Disc Replacement Market Growth & Trends:

The global artificial disc replacement market size is expected to reach USD 1.34 billion by 2030, registering to grow at a CAGR of 12.2% from 2024 to 2030 according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 11.7% from 2021 to 2028. The key factors driving the market growth include the rising number of spinal surgeries across the globe, the growing aging population, high demand for surgical alternatives with less tissue disruption, and technological advancements. The COVID-19 pandemic resulted in several challenges, such as logistical bottlenecks, low demand, and decreased sales & marketing activities.

This resulted from supply chain challenges, deferred or canceled elective procedures, and movement restrictions due to lockdowns. Zimmer Biomet, for instance, reported a negative impact of COVID-19 on its annual revenue for 2020. It reported a 12% decrease in its total revenues from 2019 to 2020. The company was also impacted by the postponed elective and semi-elective procedures that use Medtronic's products. The reluctance of people for undergoing non-COVID-19 emergency procedures affected the company's revenue.

The broader acceptance of surgical treatments along with less tissue disruption as well as patient trauma is expected to boost the growth of the market. Furthermore, market players are anticipating broader consolidation of vendors in the spine segment, which is also expected to provide opportunities in the market. This is further complemented by the rising number of technological advancements.

The market growth is also supported by the increasing number of clinical trials related to artificial discs by market players. For instance, Medtronic is sponsoring a clinical trial related to the Prestige LP Cervical Disc for treatment of the cervical degenerative disc disease, radiculopathy, and myelopathy. The study is expected to be completed by August 2022. Such activities provide various growth opportunities to the market.

Market players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, in February 2021, NuVasive, Inc. acquired Simplify Medical, developer of the Simplify Cervical Artificial Disc for cervical total disc replacement.

Artificial Disc Replacement Market Report Highlights:

• The market was valued at USD 603.9 million in 2023 and is expected to grow at a CAGR of 12.2% during the forecast period
• The rising prevalence of degenerative disc disease due to chronic back pain is increasing the number of spinal surgeries performed around the globe. This is one of the key factors driving the market growth
• The metal + plastic material type segment led the market in 2023 owing to the wide usage of plastics for manufacturing artificial discs, while the metal segment held a significant share owing to rising research activities in the segment
• The cervical disc replacement segment held the largest share of the market in 2023 owing to the high product availability
• North America led the global market in 2023 accounting for a revenue share of more than 49.97% owing to the presence of major players in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material Type
  • 1.2.2. Indication
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material Type and Indication outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Artificial disc replacement Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing number of spinal surgeries
    • 3.2.1.2. Rising technological advancements
    • 3.2.1.3. Increasing demand for surgical alternatives with less tissue disruption
    • 3.2.1.4. Growing geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations and unfavorable reimbursement scenario
• 3.3. Artificial disc replacement Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. Artificial disc replacement Market: Material Type Estimates & Trend Analysis

• 4.1. Global Artificial disc replacement Market: Material Type Dashboard
• 4.2. Global Artificial disc replacement Market: Material Type Movement Analysis
• 4.3. Global Artificial disc replacement Market by Material Type, Revenue
• 4.4. Metal
  • 4.4.1. Metal market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Metal+Plastic
  • 4.5.1. Metal+Plastic market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Artificial disc replacement Market: Indication Estimates & Trend Analysis

• 5.1. Global Artificial disc replacement Market: Indication Dashboard
• 5.2. Global Artificial disc replacement Market: Indication Movement Analysis
• 5.3. Global Artificial disc replacement Market Estimates and Forecasts, By Indication, Revenue (USD Million)
• 5.4. Cervical Disc Replacement
  • 5.4.1. Cervical Disc Replacement market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Lumbar Disc Replacement
  • 5.5.1. Lumbar Disc Replacement market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Artificial disc replacement Market: End Use Estimates & Trend Analysis

• 6.1. Global Artificial disc replacement Market: End Use Dashboard
• 6.2. Global Artificial disc replacement Market: End Use Movement Analysis
• 6.3. Global Artificial disc replacement Market Estimates and Forecasts, by End Use, Revenue (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Outpatient Facilities
  • 6.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Artificial disc replacement Market: Regional Estimates & Trend Analysis by Material Type, Indication, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key customers
  • 8.2.3. Key company market share analysis, 2023
  • 8.2.4. Medtronic
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Orthofix Medical Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Globus Medical
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Aesculap, Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. NuVasive, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. AxioMed LLC
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Zimmer Biomet
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. SpineArt SA
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Synergy Spine Solutions Inc.
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Centinel Spine
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. Johnson & Johnson
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Product benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. B Braun Melsungen
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Product benchmarking
    • 8.2.15.4. Strategic initiatives
  • 8.2.16. Evospine
    • 8.2.16.1. Company overview
    • 8.2.16.2. Financial performance
    • 8.2.16.3. Product benchmarking
    • 8.2.16.4. Strategic initiatives
  • 8.2.17. Stryker Corporation
    • 8.2.17.1. Company overview
    • 8.2.17.2. Financial performance
    • 8.2.17.3. Product benchmarking
    • 8.2.17.4. Strategic initiatives

관련자료